Takeda Pharmaceutical Co.,Ltd.

1-1, Doshomachi 4-chome, Chuo-ku,
Osaka, 540-8645
Japan,
+81-6-6204-2111
www.takeda.com

Takeda Pharmaceutical Company Limited is a Japan-based company engaged in the pharmaceutical business. Research & Development, Manufacturing, Sales and Marketing, and Import/Export of Pharmaceutical Drugs, etc.The Company operates in three business segments,Ethical, Healthcare and others.

M&A Summary

Buy vs Sell

Year ≤ '13 '14 '15 '16 '17 '18 T
Buy (0.6/yr) # 8 - - 1 1 1 11
vol $20.0B $5.2B $67.7B $93.0B
Sell (0.2/yr) # - - 1 - - - 1
vol $575M $575M
  12

Top M&A Advisors

Financial Deals
Sign-up to View
1
Sign-up to View
1
Sign-up to View
1
Legal Deals
Sign-up to View
1
Sign-up to View
1
Sign-up to View
1

Deal Values

Buy # TOTAL
> $1B Sign-up to View
$100M to $1B Sign-up to View
< $100M Sign-up to View
TOTAL Sign-up to View
Largest Shire plc
$67.7B (2018-05-08)
Sell # Total
> $1B Sign-up to View
$100M to $1B Sign-up to View
< $100M Sign-up to View
Total Sign-up to View
Largest Takeda Pharmaceutical Company - Core Respiratory Business
$575M (2015-12-16)

According to our data here at Mergr, Takeda Pharmaceutical has acquired 15 companies, including 3 in the last 5 years. A total of 6 acquisitions came from private equity firms. It has also divested 1 asset.

Takeda Pharmaceutical’s largest acquisition to date was in 2018, when it acquired Shire for $67.7B. It’s largest disclosed sale occurred in 2015, when it sold Takeda Pharmaceutical Company - Core Respiratory Business to AstraZeneca for $575M. Takeda Pharmaceutical has acquired in 6 different US states, and 4 countries. The Company’s most targeted sectors include life science (91%) and healthcare services (10%).

When analyzing the healthcare services sector as a whole, according to Mergr, in the last 3 years, there are 415 healthcare services companies that have made at least 1 acquisition, 35 have acquired at least 5 companies, and 6 have acquired more than 10 companies. The most prolific strategic healthcare services acquirer over the past 3 years is MEDNAX, with 26 acquisitions. The most prolific private equity acquirer in the healthcare services sector over the past 3 years is Nordic Capital with 7 platform acquisitions.

Join Mergr and gain access to Takeda Pharmaceutical’s M&A summary, the M&A summaries of companies just like it, as well as recent M&A activity in the healthcare services sector.


What's Mergr?

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 3.4K Private Equity Firms
  • 119K M&A Transactions
  • 129K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 2.8K M&A Advisors
    (Investment Banks and Law Firms)
  • 35K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.